Macroautophagy as a pathomechanism in sporadic inclusion body myositis

被引:2
|
作者
Lunemann, Jan D.
Schmidt, Jens
Dalakas, Marinas C.
Munz, Christian
机构
[1] Rockefeller Univ, Lab Viral Immunobiol, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA
[2] Univ Gottingen, Muscle Immunobiol Grp, Dept Neuroimmunol, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany
[4] NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA
关键词
sporadic inclusion body myositis; beta-amyloid; macroautophagy; LC3/Atg8; vacuolar myopathy;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Skeletal muscle fibers show a high level of constitutive and starvation-induced macroautophagy. Sporadic Inclusion Body Myositis (sIBM) is the most common acquired skeletal muscle disease in patients above the age of 50 years and is characterized by inflammation and intracellular accumulation of aggregate-prone proteins such as amyloid precursor protein (APP)/beta-amyloid, hyperphosphorylated tau, and presenilin. In a recent study, we found that muscle fibers of sIBM patients show increased frequencies of Atg8/ LC3(+) autophagosomes and that intracellular APP/(i-amyloid colocalized with Atg8/LC3 in degenerating fibers. Colocalization of APP/beta-amyloid with LC3(+) autophagosomes was further associated with upregulation of major histocompatibility complex (MHC) class I and class II molecules and T cell infiltration. These findings indicate that APP/beta-amyloid is a substrate for autophagy in skeletal muscle fibers and suggest that degradation of aggregate-prone proteins via macroautophagy can be linked with both immune-mediated and degenerative tissue damage. A better understanding of this pathway in skeletal muscle and in the inflammatory environment of sIBM might provide a rationale for novel therapeutic strategies targeting pathogenic protein aggregation.
引用
收藏
页码:384 / 386
页数:3
相关论文
共 50 条
  • [1] Inclusion body myositis - pathomechanism and lessons from genetics
    Murnyak, Balazs
    Bodoki, Levente
    Vincze, Melinda
    Griger, Zoltan
    Csonka, Tamas
    Szepesi, Rita
    Kurucz, Andrea
    Danko, Katalin
    Hortobagyi, Tibor
    OPEN MEDICINE, 2015, 10 (01): : 188 - 193
  • [2] Update on sporadic inclusion body myositis
    Hohlfeld, Reinhard
    BRAIN, 2011, 134 : 3141 - 3145
  • [3] β-catenin in sporadic inclusion body myositis
    Shim, C. Y.
    Bettolo, C. Marini
    Singh, P.
    Rakowicz, W.
    Lane, R. J.
    Roncaroli, F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 : 35 - 36
  • [4] Epidemiology of sporadic inclusion body myositis
    Molberg, Oyvind
    Dobloug, Cecilie
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (06) : 657 - 660
  • [5] Sporadic inclusion body myositis misdiagnosed as granulomatous myositis
    Mozaffar, T.
    Lavian, M.
    Goyal, N.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S239 - S240
  • [6] Prevalence of Sporadic Inclusion Body Myositis
    Aoife, Callan
    Capkun, Gorana
    Freitas, Rita
    Vasanthaprasad, Vijayalakshmi
    Ghosh, Shubhro
    Needham, Merrilee
    NEUROLOGY, 2016, 86
  • [7] Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis
    Lavian, Monica
    Goyal, Namita
    Mozaffar, Tahseen
    NEUROMUSCULAR DISORDERS, 2016, 26 (11) : 741 - 743
  • [8] McArdle disease and sporadic inclusion body myositis
    Scarpelli, M.
    Vattemi, G.
    Filosto, M.
    Krause, S.
    Marini, M.
    Tomelleri, G.
    Tonin, P.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 (04) : 442 - 445
  • [9] SPORADIC INCLUSION BODY MYOSITIS: A CASE COHORT
    Dimachkie, M. M.
    Dajdaj, B. K. Estephan
    Barohn, R. J.
    Herbelin, L. L.
    Pasnoor, M.
    McVey, A.
    MUSCLE & NERVE, 2011, 44 (04) : 638 - 639
  • [10] Proteomic study of sporadic inclusion body myositis
    Ke Li
    Chuanqiang Pu
    Xusheng Huang
    Jiexiao Liu
    Yanling Mao
    Xianghui Lu
    Proteome Science, 12